No abstract available
MeSH terms
-
Anticoagulants / therapeutic use
-
Biomedical Research / trends*
-
Cerebral Hemorrhage / complications
-
Cerebral Hemorrhage / therapy
-
Child
-
Delivery of Health Care
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
National Institutes of Health (U.S.)
-
Neuroprotective Agents / therapeutic use
-
Recovery of Function
-
Risk Factors
-
Stroke / etiology
-
Stroke / prevention & control
-
Stroke / therapy*
-
Stroke Rehabilitation
-
Telemedicine
-
United States
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Neuroprotective Agents